Mouse Models to Study Pro-and Antiangiogenic Potential: Novel Roles for PLGF and FLT1

Lieve Moons; Aernout Luttun; Peter Carmeliet; Ed Conway

doi:10.1007/978-1-4615-0483-2_23

Related publications

Article2008

FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?

Christian Fischer, Massimiliano Mazzone, Bart Jonckx, Peter Carmeliet

Article2007

Mouse Models for the Study of Telomerase

Marı́a A. Blasco, Han‐Woong Lee, Michael Rizen, Douglas Hanahan, Ronald A. DePinho, Carol W. Greider

Article2005

A monoclonal antibody against murine PlGF blocks primary tumor growth in syngeneic mouse tumor models

C Fischer, Mieke Dewerchin, Thien H. Ngo, Geert Reyns, A Scholz, JM Stassen, Hilde Depraetere, D Collen, Lieve Moons, Peter Carmeliet

Article2003

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

Monica Autiero, Johannes Waltenberger, Didier Communi, Andrea Kranz, Lieve Moons, Diether Lambrechts, Jens Krøll, Stéphane Plaisance, Maria De Mol, Françoise Bono, Stefanie Kliche, Guido Fellbrich, Kurt Ballmer‐Hofer, Domenico Maglione, Ulrike Mayr-Beyrle, Mieke Dewerchin, Saskia Dombrowski, Danica Stanimirovic, Paul Van Hummelen, Christoph Dehio, Daniel J. Hicklin, Graziella Persico, Jean‐Marc Herbert, David Communi,

Article2002

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

Aernout Luttun, Marc Tjwa, Lieve Moons, Yan Wu, Anne Angelillo‐Scherrer, Fang Liao, Janice A. Nagy, Andrea T. Hooper, Josef Priller, Bert De Klerck, Veerle Compernolle, Evis Daci, Peter Böhlen, Mieke Dewerchin, Jean-Marc Herbert, Roy A. Fava, Patrick Matthys, Geert Carmeliet, D Collen, Harold F. Dvorak, Daniel J. Hicklin, Peter Carmeliet